Nanocapsules of perfluorooctyl bromide for theranostics: from formulation to targeting

O. Diou; E. Fattal; T. Payen; S. L. Bridal; J. Valette; N. Tsapis

doi:10.1117/12.2037162

24 March 2014 Nanocapsules of perfluorooctyl bromide for theranostics: from formulation to targeting

O. Diou, E. Fattal, T. Payen, S. L. Bridal, J. Valette, N. Tsapis

Proceedings Volume 8955, Colloidal Nanoparticles for Biomedical Applications IX; 895514 (2014) https://doi.org/10.1117/12.2037162
Event: SPIE BiOS, 2014, San Francisco, California, United States

Abstract

The need to detect cancer at its early stages, as well as, to deliver chemotherapy to targeted site motivates many researchers to build theranostic platforms which combine diagnostic and therapy. Among imaging modalities, ultrasonography and Magnetic Resonance Imaging (MRI) are widely available, non invasive and complement each other. Both techniques often require the use of contrast agents. We have developed nanocapsules of perfluorooctyl bromide as dual contrast agent for both imaging modalities. The soft, amorphous polymer shell provides echogenicity, while the high-density perfluorinated liquid core allows detection by ¹⁹F MRI. We have used a shell of poly(lactide-co-glycolide) (PLGA) since this polymer is biodegradable, biocompatible and can be loaded with drugs. These capsules were shown to be efficient in vitro as contrast agents for both ¹⁹F MRI and ultrasonography. In addition, for in vivo applications a poly(ethyleneglycol) (PEG) coating promotes stability and prolonged circulation. Being stealth, nanocapsule can accumulate passively into implanted tumors by the EPR effect. We will present nanocapsule formulation and characterization, and will show promising in vivo results obtained for both ultrasonography and ¹⁹F MRI.

Citation Download Citation

O. Diou, E. Fattal, T. Payen, S. L. Bridal, J. Valette, and N. Tsapis "Nanocapsules of perfluorooctyl bromide for theranostics: from formulation to targeting", Proc. SPIE 8955, Colloidal Nanoparticles for Biomedical Applications IX, 895514 (24 March 2014); https://doi.org/10.1117/12.2037162

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available